Entrar Registro gratuito

Theratechnologies EPS Est. T/T

Qual é o EPS Est. T/T de Theratechnologies?

O EPS Est. T/T de Theratechnologies Inc. é -40.00%

Qual é a definição de EPS Est. T/T?



A taxa de crescimento prospectiva trimestral do EPS, ano após ano , é o aumento estimado do EPS de uma empresa para o próximo trimestre em comparação com o desempenho do trimestre passado correspondente.

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS Est. T/T de empresas na Setor Health Care em NASDAQ em comparação com Theratechnologies

O que Theratechnologies faz?

theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.

Empresas com eps est. t/t semelhantes a Theratechnologies